| Financial Year |
March 31 2023 |
| Monetary Funds |
450,069,265.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
111,310,349.43 |
| Accounts Receivable |
1,506,857,865.37 |
| Advances to Suppliers |
244,512,840.12 |
| Other Receivables |
141,929,733.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
573,796,527.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,069,997.55 |
| Total Current Assets |
3,063,744,577.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
147,783,714.00 |
| Investment Properties |
-- |
| Fixed Assetes |
376,855,652.74 |
| Under-construction Projects |
43,318,548.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
101,935,368.31 |
| R&D expenses |
-- |
| Goodwill |
232,908,808.40 |
| Long-Term Deferred and Prepaid Expenses |
29,574,613.41 |
| Deferred Income Tax Assets |
13,764,219.90 |
| Other Non-Current Assets |
38,555,000.00 |
| Sub-Total of Non-Current Assets |
1,139,835,964.67 |
| Total Assets |
4,203,580,541.74 |
| Short-Term Loans |
1,326,629,126.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
31,797,944.95 |
| Accounts Payable |
361,745,060.39 |
| Accounts Received In Advance |
716,057.43 |
| Employee Compensation Payable |
15,665,545.42 |
| Taxes Payable |
14,276,331.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
65,519,109.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
86,685,625.70 |
| Other Current Liabilities |
2,013,066.10 |
| Sub-Total of Current Liabilities |
1,917,138,249.87 |
| Long-term Loans |
311,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
440,832,428.60 |
| Total Liabilities |
2,357,970,678.47 |
| Paid-In Capital(Or Share Stock) |
206,505,700.00 |
| Capital Surplus |
994,551,091.36 |
| Surplus Reserve |
5,332,238.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
532,141,573.43 |
| Minority Stockholder's Interest |
107,079,259.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,738,530,603.31 |
| Owner's Equity（Stockholder's Equity） |
1,845,609,863.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,203,580,541.74 |
